WeVote
Log In

Bill

Bill

SB 1098

Relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.

89th Legislature (2025) Introduced by César Blanco and 2 co-sponsors

Texas SB 1098 mandates pharmacies disclose drug pricing information to patients before dispensing prescriptions, increasing medication cost transparency.

Placed on General State Calendar
#consumerprotection(i0080) #insurance--health&accident(i0422) #medicine&prescriptiondrugs(s7338) #occupationalregulation--healthoccupations(i0540) #pharmacies&pharmacists(s1192)
0
WeVote Research Nonpartisan
Bill Summary · SB 1098

Legislative bill overview

SB 1098 requires Texas pharmacies to disclose drug pricing information to patients before filling prescriptions. The bill mandates transparency about medication costs, potentially including cash prices, insurance copayments, and comparative pricing options. This applies to both prescription drugs and biological products dispensed by licensed pharmacies.

Why is this important

Prescription drug costs represent a significant healthcare expense for many Texans, and price transparency can enable patients to make informed decisions and potentially reduce out-of-pocket costs. Many patients currently lack access to price information before purchasing medications, limiting their ability to shop for better rates or explore generic alternatives. This bill addresses a real market information gap that affects healthcare affordability.

Potential points of contention

  • Implementation burden: Pharmacies may argue compliance requires new systems, staff training, and operational costs, particularly for independent and smaller pharmacies with limited IT infrastructure
  • Insurance complexity: Determining accurate cash versus insured prices can be complicated, and timing of price disclosure relative to insurance verification raises practical questions
  • Scope definition: Uncertainty about what constitutes required "price information" (cash price only, all available options, comparative pricing) could create compliance challenges and inconsistent implementation

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.